News Agency
The Times

Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development

  • Written by PR Newswire

TAIPEI, Feb. 1, 2024 /PRNewswire/ -- Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the successful completion of its Series A funding round. The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital,...

Read more: Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion